Clene director granted options for 3,030 shares

Clene Inc. director Vallerie McLaughlin was awarded a stock option covering 3,030 shares of Common Stock.

Rhea-AI Filing Summary

Clene Inc. director Vallerie McLaughlin was awarded a stock option covering 3,030 shares of Common Stock. The option was granted on February 19, 2026 under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share.

The filing shows this as a derivative acquisition with no cash paid at grant. According to the disclosure, the option vests immediately upon grant and leaves McLaughlin with 3,030 derivative shares following the transaction, reflecting a new equity-based incentive rather than an open-market share purchase.

Insider Trade Summary

Grant/Award: 3,030 shares

Grant/Award 1 txn

Insider McLaughlin Vallerie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	stock option	3,030	$0.00	$0.00

Holdings After Transaction: stock option — 3,030 contracts (Direct)

Footnotes (1)

1. F1. This option was granted on February 19, 2026 as an option for 3,030 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Clene Inc. (CLNN) director Vallerie McLaughlin report in this Form 4?

Vallerie McLaughlin reported receiving a stock option grant for 3,030 shares of Clene Inc. Common Stock. The option was awarded as a derivative acquisition and represents equity-based compensation, not an open-market transaction for existing shares.

How many Clene Inc. (CLNN) shares are covered by the new stock option grant?

The new stock option grant covers 3,030 shares of Clene Inc. Common Stock. These are underlying shares tied to the option, meaning they can potentially be acquired in the future by exercising the option at the specified exercise price.

What is the exercise price of the Clene Inc. (CLNN) stock options granted to McLaughlin?

The stock option granted to Vallerie McLaughlin has an exercise price of $4.73 per share. This is the fixed price at which she may purchase the underlying Clene Inc. shares if she chooses to exercise the option later.

When do the Clene Inc. (CLNN) stock options granted to Vallerie McLaughlin vest?

The options granted to Vallerie McLaughlin vest immediately upon grant. Immediate vesting means she is fully vested in all 3,030 option shares as of the February 19, 2026 grant date, without any additional service-based waiting period.

Under which plan were the Clene Inc. (CLNN) options to McLaughlin granted?

The options were granted under the Clene Inc. Amended 2020 Stock Plan. This plan governs equity-based compensation awards, including stock options, and sets the terms under which directors and other participants receive and exercise such incentives.

Does the Form 4 show Vallerie McLaughlin buying or selling Clene Inc. (CLNN) shares on the market?

The Form 4 does not show any open-market buying or selling of Clene Inc. shares. It reports a grant of stock options as equity compensation, classified as a derivative acquisition rather than a purchase or sale of outstanding Common Stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McLaughlin Vallerie

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$4.73	02/19/2026		A		3,030		(1)	02/18/2036	common stock	3,030	$0	3,030	D

Explanation of Responses:

1. This option was granted on February 19, 2026 as an option for 3,030 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.